CD28 and adult T-cell leukemia/lymphoma: The T-cell receptor/NF–B signaling pathway is frequently altered in ATLL [44], leading to genetic alterations in the PRKCB, PLCG1, VAV1, and CARD11 genes as well as the ICOS-CD28 and CTLA4-CD28 fusions.